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EDITORIAL
Thin glomerular basement membrane disease
Isolated microscopic hematuria that begins in child- strate that thin basement membranes were present in
between 5.2 and 9.2% of the general population [7]. Anhood and is of glomerular origin has a rather limited
differential diagnosis, with Alport syndrome, IgA ne- important step in this investigation was the demonstrated
segregation of biopsy-proved thin GBM disease with thephropathy, and benign familial hematuria as the most
prevalent conditions. In a series of 322 children with locus for autosomal-recessive Alport syndrome in 8 of
22 families [8]. In this issue of Kidney International, thepersistent hematuria for longer than 6 months, biopsies
were classified as IgA nephropathy in 78 patients, Alport same investigators showed a heterozygote mutation in
Col4A4 gene in thin GBM disease [9]. Additional molec-syndrome in 86 patients, and thin basement membrane
nephropathy in 50 patients. The biopsies in 48 patients ular abnormalities can be expected and should allow a
clearer delineation of thin GBM disease.showed normal glomeruli and one patient had a more
rare disorder [1]. What should be the strategy when a diffuse thin GBM
is found in a patient with isolated hematuria? In mostPatients with benign familial hematuria usually have
persistent hematuria, although intermittent hematuria kindred with benign familial hematuria, autosomal-dom-
inant inheritance is observed. However, in a few families,does occur in some patients. Episodic gross hematuria
the inheritance appears to be autosomal-recessive or itis rare. Proteinuria, progression to renal failure, or extra-
occurs sporadically. An X-linked Alport syndrome canrenal symptoms such as hearing loss are not present.
mostly be excluded based on the inheritance pattern. AThinning of the glomerular basement membrane (GBM),
diffuse thinning of the GBM was the only abnormalitythe hallmark of this disease, is usually uniform, but focal
seen in a 15-year-old boy with X-linked Alport syndromealteration involving at least 50% of the GBM may occur.
[10]. However, the autosomal-recessive form of AlportTo define thin GBM disease, it is important to realize
syndrome caused by mutation in COL4A3 or COL4A4that the thickness of the GBM depends on the age and
genes (found in approximately 14% of the cases) andgender of the patient. The most extensive study of GBM
the recently described autosomal-dominant form causedthickness in children was performed by Morita et al, who
by COL4A3 mutation [11] remain a possibility. Hope-calculated thickness from 100 to 340 nm at 1 year of age
fully, aberrant laminin 2 deposition in GBM, as is pres-to 190 to 440 nm at 9 years of age and older [2]. Dische
ent in X-linked and autosomal-recessive forms of Alportfound that the GBM is thinner in female patients than
syndrome [12], will not be found in thin GBM disease.in male patients [3]. Considering the differing results
obtained by investigators, the conclusion by Dische that
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